Kinetics of postop circulating cell-free DNA and impact on MRD detection rates in resected stage I-III colorectal cancer
Kinetics of postop circulating cell-free DNA and impact on MRD detection rates in resected stage I-III colorectal cancer
OPERA: Nonoperative modality (NOM) treatments of rectal cancer do not compromise the chance of cure
NIVO + chemo and NIVO + IPI continue to demonstrate clinically meaningful survival benefit vs chemo for advanced ESCC
Epidemiology, detection, and management of NAFLD: a Latin American perspective
Optimisation of supportive, palliative and end of life care
What is required to advance data ethics, data sharing, and Open Science across LMICs
Access to Oncology Medicines Coalition - The Medicines Patent Pool
Genomic testing in biliary tract cancers
Intraoperative Radiotherapy
Cancer survivors' stories: An African perspective
ERMES study suggests a strategy of de-escalation with only cetuximab in first line therapy for RAS and BRAF wild type mCRC
ESMO 2022: Highlights, commentary and analysis